Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
Jul 07, 2026
Mumbai (Maharashtra) [India], July 7: Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual...